Research Paper Volume 15, Issue 13 pp 6179—6211
ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, m6A modification, and drug susceptibility
Figure 3. Box plots exploring the relationship between ZNF765 expression and clinicopathological characteristics. (A) Age; (B) Gender; (C) Grade; (D) Stage; (E) T (size of the tumor); (F) N (lymph node metastasis).